Evelyn Ting

Triple-negative high-risk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy: results of WSG AM-01 trial

Oleg Gluz, Ulrike Nitz, Nadia Harbeck et al. · Annals of Oncology · 2008 · 102 citations

Breast Oncology, Oncology, Adjuvant Chemotherapy +6

Nuclear karyopherin α2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity

Oleg Gluz, Peter J. Wild, Robert Meiler et al. · International Journal of Cancer · 2008 · 78 citations · Full text

Tumor Biology, Treatment Intensity, Breast Oncology +13

Protein Expression Profiling in High-Risk Breast Cancer Patients Treated with High-Dose or Conventional Dose–Dense Chemotherapy

Raihanatou Diallo-Danebrock, Evelyn Ting, Oleg Gluz et al. · Clinical Cancer Research · 2007 · 70 citations · Full text

Y-Box–Binding Protein YB-1 Identifies High-Risk Patients With Primary Breast Cancer Benefiting From Rapidly Cycled Tandem High-Dose Adjuvant Chemotherapy

Oleg Gluz, Karin Mengele, Manfred Schmitt et al. · Journal of Clinical Oncology · 2009 · 47 citations · Full text

Early Stages of Calciphylaxis: Are Skin Biopsies the Answer

Joerg Latus, Martin Kimmel, German Ott et al. · Case Reports in Dermatology · 2011 · 32 citations · Full text